Answers are grounded in this paper and cite their sources.
While most subunit malaria vaccines provide only limited efficacy, pre-erythrocytic and erythrocytic genetically attenuated parasites (GAP) have been shown to confer complete sterilizing immunity. We recently generated aPlasmodium berghei(PbNK65) parasite that lacks a secreted factor, the histamine releasing factor (HRF) (PbNK65hrfΔ), and induces in infected mice a self-resolving blood stage infection accompanied by a long lasting immunity. Here, we explore the immunological mechanisms underlying the anti-parasite protective properties of the mutantPbNK65hrfΔ and demonstrate that in addition to an up-regulation of IL-6 production, CD4+but not CD8+T effector lymphocytes are indispensable for the clearance of malaria infection. Maintenance of T cell-associated protection is associated with the reduction in CD4+PD-1+and CD8+PD-1+T cell numbers. A higher number of central and effector memory B cells in mutant-infected mice also plays a pivotal role in protection. Importantly, we also demonstrate that prior infection with WT parasites followed by a drug cure does not prevent the induction ofPbNK65hrfΔ-induced protection, suggesting that such protection in humans may be efficient even in individuals that have been infected and who repeatedly received antimalarial drugs.
No takes yet. Share an insight, caveat, or question.
Demarta‐Gatsi et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: